Kristina Burow - Net Worth and Insider Trading

Kristina Burow Net Worth

The estimated net worth of Kristina Burow is at least $265 Million dollars as of 2024-12-26. Kristina Burow is the Director of Vir Biotechnology Inc and owns about 28,666,663 shares of Vir Biotechnology Inc (VIR) stock worth over $212 Million. Kristina Burow is the Director, 10% Owner of Neumora Therapeutics Inc and owns about 4,144,827 shares of Neumora Therapeutics Inc (NMRA) stock worth over $47 Million. Kristina Burow is also the Director, 10% Owner of Boundless Bio Inc and owns about 2,230,199 shares of Boundless Bio Inc (BOLD) stock worth over $6 Million. Besides these, Kristina Burow also holds Metacrine Inc (MTCR) . Details can be seen in Kristina Burow's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kristina Burow has not made any transactions after 2024-04-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Kristina Burow

Kristina Burow Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kristina Burow owns 13 companies in total, including Metacrine Inc (MTCR) , Unity Biotechnology Inc (UBX) , and Gossamer Bio Inc (GOSS) among others .

Click here to see the complete history of Kristina Burow’s form 4 insider trades.

Insider Ownership Summary of Kristina Burow

Ticker	Comapny	Transaction Date	Type of Owner
MTCR	Metacrine Inc	2020-09-18	director
UBX	Unity Biotechnology Inc	2020-06-18	director
GOSS	Gossamer Bio Inc	2019-02-07	director
		2018-05-23	director
		2019-10-16	director
		2020-02-05	director
		2019-05-30	director & 10 percent owner
		2021-07-15	10 percent owner
		2021-02-03	10 percent owner
		2021-06-16	10 percent owner
		2021-07-27	10 percent owner
		2022-10-19	10 percent owner
		2023-11-14	director & 10 percent owner

Kristina Burow Latest Holdings Summary

Kristina Burow currently owns a total of 4 stocks. Among these stocks, Kristina Burow owns 28,666,663 shares of Vir Biotechnology Inc (VIR) as of October 16, 2019, with a value of $212 Million and a weighting of 79.98%. Kristina Burow owns 4,144,827 shares of Neumora Therapeutics Inc (NMRA) as of November 14, 2023, with a value of $47 Million and a weighting of 17.82%. Kristina Burow also owns 2,230,199 shares of Boundless Bio Inc (BOLD) as of April 2, 2024, with a value of $6 Million and a weighting of 2.2%. The other 1 stocks Metacrine Inc (MTCR) have a combined weighting of 0% among all his current holdings.

Latest Holdings of Kristina Burow

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
VIR	Vir Biotechnology Inc	2019-10-16	28,666,663	7.39	211,846,640
NMRA	Neumora Therapeutics Inc	2023-11-14	4,144,827	11.39	47,209,580
BOLD	Boundless Bio Inc	2024-04-02	2,230,199	2.61	5,820,819
MTCR	Metacrine Inc	2020-09-18	297,468	0.00	416

Holding Weightings of Kristina Burow

Kristina Burow Form 4 Trading Tracker

According to the SEC Form 4 filings, Kristina Burow has made a total of 0 transactions in Vir Biotechnology Inc (VIR) over the past 5 years. The most-recent trade in Vir Biotechnology Inc is the acquisition of 1,000,000 shares on October 16, 2019, which cost Kristina Burow around $20 Million.

According to the SEC Form 4 filings, Kristina Burow has made a total of 7 transactions in Neumora Therapeutics Inc (NMRA) over the past 5 years, including 7 buys and 0 sells. The most-recent trade in Neumora Therapeutics Inc is the acquisition of 35,010 shares on November 14, 2023, which cost Kristina Burow around $412,068.

According to the SEC Form 4 filings, Kristina Burow has made a total of 1 transactions in Boundless Bio Inc (BOLD) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Boundless Bio Inc is the acquisition of 200,000 shares on April 2, 2024, which cost Kristina Burow around $3 Million.

More details on Kristina Burow's insider transactions can be found in the Insider Trading History of Kristina Burow table.

Insider Trading History of Kristina Burow

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kristina Burow Trading Performance

GuruFocus tracks the stock performance after each of Kristina Burow's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kristina Burow is 23.97%. GuruFocus also compares Kristina Burow's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kristina Burow within 3 months outperforms 8 times out of 10 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Kristina Burow's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Kristina Burow

Average Return

Average return per transaction

Outperforming Transactions

6 out of 9 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	-3.26
Relative Return to S&P 500(%)	-3.84

Kristina Burow Ownership Network

Ownership Network List of Kristina Burow

No Data

Ownership Network Relation of Kristina Burow

Kristina Burow Owned Company Details

What does Metacrine Inc do?

Who are the key executives at Metacrine Inc?

Kristina Burow is the director of Metacrine Inc. Other key executives at Metacrine Inc include Chief Business Officer Michael York , director & President & CEO Preston Klassen , and 10 percent owner Braden Michael Leonard .

Metacrine Inc (MTCR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Metacrine Inc (MTCR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Metacrine Inc (MTCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Metacrine Inc (MTCR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Metacrine Inc Insider Transactions

No Available Data

What does Unity Biotechnology Inc do?

Who are the key executives at Unity Biotechnology Inc?

Kristina Burow is the director of Unity Biotechnology Inc. Other key executives at Unity Biotechnology Inc include See Remarks Alexander Hieu Nguyen , director & Chief Executive Officer Anirvan Ghosh , and See Remarks Lynne Marie Sullivan .

Unity Biotechnology Inc (UBX) Insider Trades Summary

Over the past 18 months, Kristina Burow made no insider transaction in Unity Biotechnology Inc (UBX). Other recent insider transactions involving Unity Biotechnology Inc (UBX) include a net sale of 7,993 shares made by Anirvan Ghosh , a net sale of 599 shares made by Lynne Marie Sullivan , and a net sale of 381 shares made by Alexander Hieu Nguyen .

In summary, during the past 3 months, insiders sold 717 shares of Unity Biotechnology Inc (UBX) in total and bought 0 shares, with a net sale of 717 shares. During the past 18 months, 8,973 shares of Unity Biotechnology Inc (UBX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 8,973 shares.

Unity Biotechnology Inc (UBX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Unity Biotechnology Inc Insider Transactions

No Available Data

What does Gossamer Bio Inc do?

Who are the key executives at Gossamer Bio Inc?

Kristina Burow is the director of Gossamer Bio Inc. Other key executives at Gossamer Bio Inc include Chief Medical Officer Richard Aranda , director & Executive Chairman Faheem Hasnain , and Chief Financial Officer Bryan Giraudo .

Gossamer Bio Inc (GOSS) Insider Trades Summary

Over the past 18 months, Kristina Burow made no insider transaction in Gossamer Bio Inc (GOSS). Other recent insider transactions involving Gossamer Bio Inc (GOSS) include a net purchase of 293,570 shares made by Bryan Giraudo , a net purchase of 348,828 shares made by Faheem Hasnain , and a net sale of 5,926 shares made by Richard Aranda .

In summary, during the past 3 months, insiders sold 0 shares of Gossamer Bio Inc (GOSS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 45,976 shares of Gossamer Bio Inc (GOSS) were sold and 729,000 shares were bought by its insiders, resulting in a net purchase of 683,024 shares.

Gossamer Bio Inc (GOSS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Gossamer Bio Inc Insider Transactions

No Available Data

What does Scholar Rock Holding Corp do?

Who are the key executives at Scholar Rock Holding Corp?

Kristina Burow is the director of Scholar Rock Holding Corp. Other key executives at Scholar Rock Holding Corp include 10 percent owner Invus Public Equities, L.p. , Chief Medical Officer Jing L. Marantz , and Chief Commercial Officer Tracey Sacco .

Scholar Rock Holding Corp (SRRK) Insider Trades Summary

Over the past 18 months, Kristina Burow made no insider transaction in Scholar Rock Holding Corp (SRRK). Other recent insider transactions involving Scholar Rock Holding Corp (SRRK) include a net sale of 336,643 shares made by Edward H Myles , a net sale of 35,372 shares made by Mo Qatanani , and a net sale of 13,709 shares made by Caryn Parlavecchio .

In summary, during the past 3 months, insiders sold 3,578,573 shares of Scholar Rock Holding Corp (SRRK) in total and bought 0 shares, with a net sale of 3,578,573 shares. During the past 18 months, 3,729,751 shares of Scholar Rock Holding Corp (SRRK) were sold and 6,579,493 shares were bought by its insiders, resulting in a net purchase of 2,849,742 shares.

Scholar Rock Holding Corp (SRRK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Scholar Rock Holding Corp Insider Transactions

No Available Data

What does Vir Biotechnology Inc do?

Who are the key executives at Vir Biotechnology Inc?

Kristina Burow is the director of Vir Biotechnology Inc. Other key executives at Vir Biotechnology Inc include Chief Executive Officer Backer Marianne De , Chief Technology Officer Ann M. Hanly , and Chief Financial Officer Sung Lee .

Vir Biotechnology Inc (VIR) Insider Trades Summary

Over the past 18 months, Kristina Burow made no insider transaction in Vir Biotechnology Inc (VIR). Other recent insider transactions involving Vir Biotechnology Inc (VIR) include a net sale of 8,223 shares made by , a net sale of 97,652 shares made by Svf Endurance (cayman) Ltd , and a net sale of 55,500 shares made by George A Scangos .

In summary, during the past 3 months, insiders sold 8,223 shares of Vir Biotechnology Inc (VIR) in total and bought 0 shares, with a net sale of 8,223 shares. During the past 18 months, 307,464 shares of Vir Biotechnology Inc (VIR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 307,464 shares.

Vir Biotechnology Inc (VIR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Vir Biotechnology Inc Insider Transactions

No Available Data

What does Beam Therapeutics Inc do?

Who are the key executives at Beam Therapeutics Inc?

Kristina Burow is the director of Beam Therapeutics Inc. Other key executives at Beam Therapeutics Inc include President & CSO Giuseppe Ciaramella , Chief Legal Officer Christine Bellon , and director & CEO John M. Evans .

Beam Therapeutics Inc (BEAM) Insider Trades Summary

Over the past 18 months, Kristina Burow made no insider transaction in Beam Therapeutics Inc (BEAM). Other recent insider transactions involving Beam Therapeutics Inc (BEAM) include a net sale of 16,081 shares made by Christine Bellon , a net sale of 263,284 shares made by Giuseppe Ciaramella , and a net sale of 198,102 shares made by John M. Evans .

In summary, during the past 3 months, insiders sold 162,894 shares of Beam Therapeutics Inc (BEAM) in total and bought 0 shares, with a net sale of 162,894 shares. During the past 18 months, 1,413,543 shares of Beam Therapeutics Inc (BEAM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,413,543 shares.

Beam Therapeutics Inc (BEAM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Beam Therapeutics Inc Insider Transactions

No Available Data

What does Sienna Biopharmaceuticals Inc do?

Who are the key executives at Sienna Biopharmaceuticals Inc?

Kristina Burow is the director & 10 percent owner of Sienna Biopharmaceuticals Inc. Other key executives at Sienna Biopharmaceuticals Inc include Chief Financial Officer Alexander Azoy , Chief Medical Officer Paul F. Lizzul , and director & President & CEO Iii Frederick Beddingfield .

Sienna Biopharmaceuticals Inc (SNNAQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sienna Biopharmaceuticals Inc (SNNAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sienna Biopharmaceuticals Inc (SNNAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sienna Biopharmaceuticals Inc (SNNAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sienna Biopharmaceuticals Inc Insider Transactions

No Available Data

What does Erasca Inc do?

Who are the key executives at Erasca Inc?

Kristina Burow is the 10 percent owner of Erasca Inc. Other key executives at Erasca Inc include director & 10 percent owner & See Remarks Jonathan E Lim , Chief Medical Officer Shannon Morris , and General Counsel Ebun Garner .

Erasca Inc (ERAS) Insider Trades Summary

Over the past 18 months, Kristina Burow made no insider transaction in Erasca Inc (ERAS). Other recent insider transactions involving Erasca Inc (ERAS) include a net purchase of 2,000,000 shares made by Jonathan E Lim , a net purchase of 110,000 shares made by Alexander W. Casdin , and a net purchase of 10,000 shares made by Start Valerie Denise Harding .

In summary, during the past 3 months, insiders sold 0 shares of Erasca Inc (ERAS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Erasca Inc (ERAS) were sold and 2,120,000 shares were bought by its insiders, resulting in a net purchase of 2,120,000 shares.

Erasca Inc (ERAS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Erasca Inc Insider Transactions

No Available Data

What does Sana Biotechnology Inc do?

Who are the key executives at Sana Biotechnology Inc?

Kristina Burow is the 10 percent owner of Sana Biotechnology Inc. Other key executives at Sana Biotechnology Inc include director & Head of SanaX Richard Mulligan , 10 percent owner Keith Crandell , and 10 percent owner Arch Venture Fund X Overage, L.p. .

Sana Biotechnology Inc (SANA) Insider Trades Summary

Over the past 18 months, Kristina Burow made no insider transaction in Sana Biotechnology Inc (SANA). Other recent insider transactions involving Sana Biotechnology Inc (SANA) include a net purchase of 1,818,181 shares made by Arch Venture Fund X Overage, L.p. , a net purchase of 1,818,181 shares made by Keith Crandell , and a net purchase of 1,818,181 shares made by Robert Nelsen .

In summary, during the past 3 months, insiders sold 0 shares of Sana Biotechnology Inc (SANA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 400,000 shares of Sana Biotechnology Inc (SANA) were sold and 5,454,543 shares were bought by its insiders, resulting in a net purchase of 5,054,543 shares.

Sana Biotechnology Inc (SANA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sana Biotechnology Inc Insider Transactions

No Available Data

What does Verve Therapeutics Inc do?

Who are the key executives at Verve Therapeutics Inc?

Kristina Burow is the 10 percent owner of Verve Therapeutics Inc. Other key executives at Verve Therapeutics Inc include Chief Financial Officer Allison Dorval , See Remarks Andrew D. Ashe , and Chief Administrative Officer Joan Nickerson .

Verve Therapeutics Inc (VERV) Insider Trades Summary

Over the past 18 months, Kristina Burow made no insider transaction in Verve Therapeutics Inc (VERV). Other recent insider transactions involving Verve Therapeutics Inc (VERV) include a net sale of 1,109 shares made by Allison Dorval , a net purchase of 1,800,000 shares made by Krishna Yeshwant , and a net purchase of 76,000 shares made by Andrew D. Ashe .

In summary, during the past 3 months, insiders sold 555 shares of Verve Therapeutics Inc (VERV) in total and bought 0 shares, with a net sale of 555 shares. During the past 18 months, 2,623 shares of Verve Therapeutics Inc (VERV) were sold and 1,876,000 shares were bought by its insiders, resulting in a net purchase of 1,873,377 shares.

Verve Therapeutics Inc (VERV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Verve Therapeutics Inc Insider Transactions

No Available Data

What does DA32 Life Science Tech Acquisition Corp do?

Who are the key executives at DA32 Life Science Tech Acquisition Corp?

Kristina Burow is the 10 percent owner of DA32 Life Science Tech Acquisition Corp. Other key executives at DA32 Life Science Tech Acquisition Corp include director & 10 percent owner Keith Crandell , director & 10 percent owner & other: Director by deputization Deerfield Management Company, L.p. (series C) , and 10 percent owner & other: Director by Deputization Section 32 Fund 3, Lp .

DA32 Life Science Tech Acquisition Corp (DALS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of DA32 Life Science Tech Acquisition Corp (DALS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of DA32 Life Science Tech Acquisition Corp (DALS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

DA32 Life Science Tech Acquisition Corp (DALS)'s detailed insider trading history can be found in Insider Trading Tracker table.

DA32 Life Science Tech Acquisition Corp Insider Transactions

No Available Data

What does Prime Medicine Inc do?

Who are the key executives at Prime Medicine Inc?

Kristina Burow is the 10 percent owner of Prime Medicine Inc. Other key executives at Prime Medicine Inc include director & 10 percent owner Robert Nelsen , 10 percent owner Arch Venture Partners X, Llc , and 10 percent owner Gv 2019 Gp, L.l.c. .

Prime Medicine Inc (PRME) Insider Trades Summary

Over the past 18 months, Kristina Burow made no insider transaction in Prime Medicine Inc (PRME). Other recent insider transactions involving Prime Medicine Inc (PRME) include a net purchase of 3,200,000 shares made by Arch Venture Partners X, Llc , a net purchase of 3,200,000 shares made by Arch Venture Partners Xii, Llc , and a net purchase of 3,200,000 shares made by Robert Nelsen .

In summary, during the past 3 months, insiders sold 0 shares of Prime Medicine Inc (PRME) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Prime Medicine Inc (PRME) were sold and 9,600,000 shares were bought by its insiders, resulting in a net purchase of 9,600,000 shares.

Prime Medicine Inc (PRME)'s detailed insider trading history can be found in Insider Trading Tracker table.

Prime Medicine Inc Insider Transactions

No Available Data

What does Neumora Therapeutics Inc do?

Who are the key executives at Neumora Therapeutics Inc?

Kristina Burow is the director & 10 percent owner of Neumora Therapeutics Inc. Other key executives at Neumora Therapeutics Inc include Head of R&D Robert A. Lenz , Chief Financial Officer Joshua Pinto , and 10 percent owner Arch Venture Partners Xii, Llc .

Neumora Therapeutics Inc (NMRA) Insider Trades Summary

Over the past 18 months, Kristina Burow made 7 insider transaction in Neumora Therapeutics Inc (NMRA) with a net purchase of 2,007,064. Other recent insider transactions involving Neumora Therapeutics Inc (NMRA) include a net purchase of 507,064 shares made by Arch Venture Partners Xii, Llc , a net sale of 88,235 shares made by Robert A. Lenz , and a net sale of 100,000 shares made by Joshua Pinto .

In summary, during the past 3 months, insiders sold 35,611 shares of Neumora Therapeutics Inc (NMRA) in total and bought 0 shares, with a net sale of 35,611 shares. During the past 18 months, 210,023 shares of Neumora Therapeutics Inc (NMRA) were sold and 7,293,833 shares were bought by its insiders, resulting in a net purchase of 7,083,810 shares.

Neumora Therapeutics Inc (NMRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Neumora Therapeutics Inc Insider Transactions

No Available Data

Kristina Burow Mailing Address

Above is the net worth, insider trading, and ownership report for Kristina Burow. You might contact Kristina Burow via mailing address: 8755 W. Higgins Road, Suite 1025, Chicago Il 60631.

Discussions on Kristina Burow

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.